4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000093
Chief Executive Officer sold 11,085 shares at $36.67 ($406,487)
- Chief Executive Officer acquired 22,691 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-08 | Exercise or conversion : show line 1 in the form 10b5-1 | +22,691 | 134,613 | D | ||
| 2025-08-08 | Sale : show line 2 in the form 10b5-1 | −11,085 | $36.67 | $406,487 | 123,528 | D |
| Open-market sales · 11,085 sh · avg $36.67 · $406,487 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-08-08 | Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units | −22,691 | 0 | D |
Loading xslF345X05/wk-form4_1755030260.xml…